Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine - 12, 99 - 106 (2005)
Published online: 4 December 2005; | doi:10.1038/nm1332

IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-bold beta1 production and fibrosis

Stefan Fichtner-Feigl1, 2, Warren Strober1, Koji Kawakami3, Raj K Puri3 & Atsushi Kitani1

1  Mucosal Immunity Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10-CRC 5W3864, 10 Center Drive, Bethesda, Maryland 20892, USA.

2  Department of Surgery, University of Regensburg Medical Center, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany.

3  Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, National Institutes of Health, Building 29B, 2NN10, 29 Lincoln Drive MSC 4555, Bethesda, Maryland 20892, USA.

Correspondence should be addressed to Warren Strober wstrober@niaid.nih.gov

Interleukin (IL)-13 is a major inducer of fibrosis in many chronic infectious and autoimmune diseases. In studies of the mechanisms underlying such induction, we found that IL-13 induces transforming growth factor (TGF)-beta1 in macrophages through a two-stage process involving, first, the induction of a receptor formerly considered to function only as a decoy receptor, IL-13Ralpha2. Such induction requires IL-13 (or IL-4) and tumor necrosis factor (TNF)-alpha. Second, it involves IL-13 signaling through IL-13Ralpha2 to activate an AP-1 variant containing c-jun and Fra-2, which then activates the TGFB1 promoter. In vivo, we found that prevention of IL-13Ralpha2 expression reduced production of TGF-beta1 in oxazolone-induced colitis and that prevention of IL-13Ralpha2 expression, Il13ra2 gene silencing or blockade of IL-13Ralpha2 signaling led to marked downregulation of TGF-beta1 production and collagen deposition in bleomycin-induced lung fibrosis. These data suggest that IL-13Ralpha2 signaling during prolonged inflammation is an important therapeutic target for the prevention of TGF-beta1–mediated fibrosis.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Decoy receptor springs to life and eases fibrosis

Nature Medicine News and Views (01 Jan 2006)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
rights and permissionsRights and permissions
Order commercial reprintsOrder commercial reprints
CrossRef lists 42 articles citing this articleCrossRef lists 42 articles citing this article
Save this linkSave this link
Figures & Tables
Supplementary info
See also: News and Views by MacDonald
Export citation

Open Innovation Challenges

naturejobs

natureproducts

Search buyers guide:

 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2006 Nature Publishing Group | Privacy policy